| |
7th Peds Wk: Atazanavir Pharmacokinetics-Pharmacodynamics in HIV-1-Infected Children Aged 3 Months to <11 Years Treated With Atazanavir Powder/Ritonavir Liquid: PRINCE-1 & -2 Studies
|
| |
| |
Reported by Jules Levin
7th International Workshop on HIV Pediatrics, July 17-18, 2015, Vancouver, British Columbia, Canada
H. Sevinsky1, L. Zaru2, R. Wang2, X. Xu1, C. Pikora3, T. Correll1, T. Eley1
1Bristol-Myers Squibb, Princeton, NJ, USA; 2Bristol-Myers Squibb, Hopewell, NJ, USA; 3Bristol-Myers Squibb, Wallingford, CT, USA
|
|
| |
| |
|
|
|
